, was a substrate for protein kinase C. Phosphorylation of a purified S26A mutant maltose-binding protein-Opi1p fusion protein by the kinase was reduced when compared with the wild-type protein. 
CDP-choline pathway (1) (2) (3) (4) (5) (6) (Fig. 1) . Wild-type cells primarily synthesize PC by the CDP-DG pathway when they are grown in the absence of exogenous choline (1) (2) (3) (4) (5) (6) . However, the CDPcholine pathway contributes to PC synthesis under this growth condition (5, 7) . The PC synthesized via the CDP-DG pathway is constantly hydrolyzed to free choline and PA by the reaction catalyzed by phospholipase D (7) . The free choline is incorporated back into PC via the CDP-choline pathway and the PA is incorporated back into phospholipids (e.g. PI) via CDP-DG (7) (Fig. 1) . The CDP-choline pathway is essential for mutants defective in CDP-DG pathway enzymes. Mutants defective in the synthesis of PS, PE, or PC require choline for growth in order to synthesize PC via the CDP-choline pathway (1) (2) (3) (4) (5) (6) . Mutants defective in the synthesis of PS and PE can also synthesize PC if they are supplemented with ethanolamine (1) (2) (3) (4) (5) (6) . The ethanolamine is utilized in the CDP-ethanolamine pathway for the synthesis of PE, which is then methylated to form PC in the CDP-DG pathway (1) (2) (3) (4) (5) (6) (Fig. 1) .
A number of factors regulate phospholipid synthesis in S. cerevisiae. These include water-soluble phospholipid precursors, nucleotides, lipids, and growth phase (1) (2) (3) (4) (5) (6) . Phospholipid synthesis regulation is complex and occurs by genetic and biochemical mechanisms. The water-soluble phospholipid precursor of PI, namely inositol ( Fig. 1) , plays a major role in the genetic regulation of phospholipid synthesis (1, 2, 4 -6) . Enzymes in the CDP-DG (e.g. encoded by the CDS1, CHO1/PSS, PSD1, CHO2/PEM1, and OPI3/PEM2) and CDP-choline (e.g. encoded by CKI1 and CPT1) pathways, as well as inositol-1-phosphate synthase (encoded by INO1), are repressed by inositol supplementation (1, 2, 4 -6) . Repression by inositol is enhanced by the inclusion of choline in the growth medium (1, 2, 4 -6) . The regulation by inositol supplementation involves the transcriptional regulatory proteins Ino2p, Ino4p, and Opi1p (1, 2, 4 -6) . Regulation of the co-regulated enzymes by inositol is mediated by a UAS INO cis-acting element (1, 8, 9) present in the promoters of their structural genes (1, 2, 4 -6) . The UAS INO element contains the binding site for an Ino2p/ Ino4p heterodimer, which is necessary for maximum expression of the co-regulated UAS INO -containing genes (4 -6, 10, 11) . Repression of the co-regulated genes requires Opi1p (12, 13) . Opi1p contains a leucine zipper and two glutamine-rich domains (13) . These motifs, which are generally associated with DNA-binding proteins (13) , are indispensable for Opi1p repressor function (14) . Opi1p mediates its negative regulatory role through the UAS INO element (15) . However, it does not interact with the UAS INO element directly or with Ino2p or Ino4p (14, 16) . The mechanism of Opi1p activity is not yet fully understood.
To gain further insight into the transcriptional regulation of phospholipid synthesis genes from S. cerevisiae, we initiated studies to examine the posttranslational modification of the Opi1p regulatory protein by phosphorylation via protein kinase C. Phosphorylation is a mechanism by which the function of a regulatory protein may be controlled (17, 18) . Protein kinase C is a transducer of lipid second messengers (19 -21) and plays a central role in the regulation of a host of cellular functions, including cell growth and proliferation (22) (23) (24) . In this study, we demonstrated that Opi1p was phosphorylated by protein kinase C, and that a major site of phosphorylation was Ser 26 . Moreover, a S26A mutant Opi1p protein caused reduced INO1 expression. Elimination of functional Opi1p by deletion of the OPI1 gene results in higher levels of INO1 expression, indicating that Opi1p functions as a negative regulator. Since a mutation reducing phosphorylation of Opi1p has an effect opposite of an opi1⌬ mutation (i.e. reduction in INO1 expression versus deletion), we hypothesize that phosphorylation at Ser 26 functions to inactivate Opi1p and attenuate its activity.
EXPERIMENTAL PROCEDURES
Materials-All the chemicals were reagent-grade. Growth medium supplies were purchased from Difco Laboratories. Restriction endonucleases, modifying enzymes, recombinant Vent DNA polymerase, pMAL-c2 vector (25) , amylose-agarose affinity chromatography resin, MBP, anti-MBP antibodies, and factor Xa protease were purchased from New England Biolabs. Genosys Biotechnologies, Inc. prepared the oligonucleotides used for PCR and DNA sequencing. The QuikChange site-directed mutagenesis kit was purchased from Stratagene. Phenylmethylsulfonyl fluoride, bovine serum albumin, histone, benzamidine, aprotinin, leupeptin, pepstatin, standard phosphoamino acids, nitrocellulose paper, and O-nitrophenyl ␤-D-galactopyranoside were purchased from Sigma. CNBr was obtained from Aldrich. Radiochemicals were purchased from PerkinElmer Life Sciences. Phosphocellulose filters were purchased from Pierce. Protein assay reagents, electrophoretic reagents, immunochemical reagents, and isopropyl-␤-D-thiogalactoside were purchased from Bio-Rad. Mouse monoclonal anti-HA antibodies (12CA5) were from Roche Molecular Biochemicals. Purified rat brain protein kinase C was purchased from Promega. PKC1-encoded ZZtagged protein kinase C was partially purified from S. cerevisiae (26) . Protein A-Sepharose, polyvinylidene difluoride membrane, and the enhanced chemifluorescence Western blotting detection kit were purchased from Amersham Pharmacia Biotech. PS and DG were purchased from Avanti Polar Lipids. Cellulose thin layer sheets were from EM Science. Scintillation counting supplies and acrylamide solutions were purchased from National Diagnostics. Peptides GVLKQSCRQK, GV-LKQACRQK, ILDRVSNKII, MSIESKKRLV, and ANKQLSDKIS were synthesized and purified commercially by Bio-Synthesis, Inc.
Strains, Plasmids, Oligonucleotides, and Growth Conditions-The strains and plasmids, and oligonucleotides used in this work are listed in Tables I and II, respectively . Escherichia coli strain DH5␣ was used for the propagation of plasmids and the production of MBP-Opi1p fusion protein directed by the inducible pMAL-c2-OPI1 plasmids. Cells were grown in LB medium (1% tryptone, 0.5% yeast extract, 1% NaCl, pH 7.4) at 37°C. Ampicillin (150 g/ml) was added to cultures of DH5␣-carrying plasmids. For the production of MBP-Opi1p fusion proteins, cultures (250 ml) were grown to the exponential phase (A 600 nm ϭ 0.4 -0.6) at 37°C, harvested, and resuspended in fresh medium containing 0.6 mM isopropyl-␤-D-thiogalactoside. After incubation for 3 h at 30°C, cells were harvested, washed with 10 mM Tris-HCl buffer (pH 7.4) containing 0.2 M NaCl, 10 mM 2-mercaptoethanol, and 1 mM Na 2 EDTA, and then frozen at Ϫ70°C. The induction was carried out at 30°C to reduce the degradation of the fusion proteins. Methods for yeast growth were performed as described previously (27, 28) . Yeast cultures were grown in YEPD medium (1% yeast extract, 2% peptone, 2% glucose) or in synthetic complete (SC) medium minus inositol (29) containing 2% glucose at 30°C. For selection of cells bearing plasmids, appropriate amino acids were omitted from SC medium. Cell numbers in liquid media were determined spectrophotometrically at an absorbance of 600 nm. Media were supplemented with 2% agar for growth on plates. An opi1⌬ mutant was constructed in strain WCG4 (30) using an opi1⌬::kanMx deletion cassette. The kanMX module, flanked by OPI1 coding sequences, was amplified by PCR (primers: OPI-S1 and OPI-S2) using plasmid pFA6aKanMX4 (31) as the template. The opi1⌬::kanMx deletion cassette was transformed into WCG4 to delete the chromosomal copy of the OPI1 gene by the one-step gene replacement technique (32) . Transformants were selected on YEPD plates containing Geneticin (G418) (31) . Deletion of the chromosomal copy of the OPI1 gene was confirmed by PCR (primers: OPI-A1 and OPI-A2) using genomic DNA isolated from the transformed colonies. One of the opi1⌬ mutants that we isolated was designated strain SH1100. This opi1⌬ mutant exhibited the inositol excretion phenotype that was characteristic of other opi1 mutants (12) . The inositol excretion phenotype was examined on SC medium plates (minus inositol) by using growth of the inositol auxotrophic mutant strain MC13 (ino1) (29) as described by McGee et al. (33) .
DNA Manipulations, Amplification of DNA by PCR, Site-directed Mutagenesis, and DNA Sequencing-Plasmid DNA preparation, restriction enzyme digestion, and DNA ligations were performed by standard methods (28) . Transformation of yeast (34) and E. coli (28) were performed as described previously. Conditions for the amplification of DNA by PCR were optimized as described previously (35) . Site-directed mutagenesis was performed by PCR using the QuikChange site-directed mutagenesis kit. DNA sequencing reactions were performed by the dideoxy method using Taq polymerase (28 A more comprehensive description of these pathways that includes additional steps can be found elsewhere (2, 5) . PME, phosphatidylmonomethylethanolamine; PDE, phosphatidyldimethylethanolamine; TG, triacylglycerol; PGP, phosphatidylglycerophosphate; PG, phosphatidylglycerol; CL, cardiolipin; other abbreviations are defined in Footnote 1.
into the same restriction site in pJH354 to form plasmid pSA1. Plasmid pSA2, which bears the HA-OPI1 S26A mutation, was derived from plasmid pSA1 after site-directed mutagenesis by PCR (primers: ASR1 and ASR2). Plasmids pSA3 and pSA4 are single-copy plasmids that contain the wild-type HA-OPI1 gene and the HA-OPI1 S26A mutation, respectively. The HA-OPI1 gene from pSA1 and the HA-OPI1 S26A mutant from pSA2 were cloned into the SacI/HindIII site of plasmid pRS415 to form plasmids pSA3 and pSA4, respectively. These plasmid constructions were confirmed by DNA sequencing.
Purification of MBP-Opi1p Fusion Proteins-All steps were performed at 4°C. Frozen E. coli cells containing the induced MBP-Opi1p fusion proteins were suspended in 10 mM Tris-HCl buffer (pH 7.4) containing 0.2 M NaCl, 10 mM 2-mercaptoethanol, 1 mM Na 2 EDTA, and 1 mM phenylmethylsulfonyl fluoride. Cells were disrupted with a French press at 10,000 p.s.i. The extract was then centrifuged at 20,000 ϫ g for 30 min to remove unbroken cells and cell debris. The supernatant (ϳ70 mg of protein) was applied to an amylose-agarose affinity chromatography column (0.6 ϫ 7 cm) equilibrated with 10 mM Tris-HCl buffer (pH 7.4) containing 0.2 M NaCl, 10 mM 2-mercaptoethanol, 1 mM Na 2 EDTA, and 1 mM phenylmethylsulfonyl fluoride. The column was washed with 10 column volumes of the same buffer to remove unbound protein from the column. The MBP-Opi1p fusion proteins were eluted from the column with chromatography buffer containing 10 mM maltose as described in the instructions provided by the manufacturer.
Preparations of Yeast Cell Extracts, Assay of ␤-Galactosidase Activity, and Immunoblot Analysis-Yeast cells were disrupted with glass beads (36) in 50 mM Tris-maleate buffer (pH 7.0) containing 1 mM Na 2 EDTA, 0.3 M sucrose, 10 mM 2-mercaptoethanol, 0.5 mM phenylmethylsulfonyl fluoride, 1 mM benzamidine, and 5 g/ml each of aprotinin, leupeptin, and pepstatin. Glass beads and unbroken cells were removed by centrifugation at 1,500 ϫ g for 10 min. The supernatant (cell extract) was used for the assay of ␤-galactosidase activity and immunoblot analysis of HA-tagged Opi1p proteins. ␤-Galactosidase activity was measured at 25°C by following the conversion of O-nitrophenyl ␤-D-galactopyranoside to O-nitrophenol (molar extinction coefficient of 3,500 M Ϫ1 cm Ϫ1 ) at 410 nm on a recording spectrophotometer (37). The reaction mixture contained 100 mM sodium phosphate buffer (pH 7.0), 3 mM O-nitrophenyl ␤-D-galactopyranoside, 1 mM MgCl 2 , 100 mM 2-mercaptoethanol, and enzyme protein in a total volume of 0.1 ml. The average standard deviation of the enzyme assays (performed in triplicate) was Ϯ5%. The enzyme reactions were linear with time and protein concentration. A unit of enzymatic activity was defined as the amount of enzyme that catalyzed the formation of 1 mol of product/ min unless otherwise indicated. Specific activity was defined as units/mg of protein. Protein concentration was determined by the method of Bradford (38) using bovine serum albumin as the standard. Statistical analyses were performed with SigmaPlot 5.0 software. SDSpolyacrylamide gel electrophoresis (39) and immunoblotting (40) using polyvinylidene difluoride membranes were performed as described previously. Anti-Opi1p antibodies (41) and anti-HA antibodies were used at a dilution of 1:500. Proteins were detected on immunoblots using the enhanced chemifluorescence Western blotting detection kit as described by the manufacturer and acquired by fluorimaging analysis. Immunoblot signals were in the linear range of detectability.
In Vivo Labeling of HA-tagged Opi1p Proteins-Cells (opi1⌬ mutant) P i (0.25 mCi/ml) for 3 h. Following the incubation, the labeled cells were harvested by centrifugation, washed, and disrupted in 50 mM Tris-HCl (pH 8.0), 150 mM NaCl, 1% Nonidet P-40, 0.5% sodium deoxycholate, 0.1% SDS, and protease and phosphatase inhibitors (radioimmune immunoprecipitation buffer) (42) . The protease and phosphatase inhibitors included 0.5 mM phenylmethylsulfonyl fluoride, 1 mM benzamide, 5 g/ml aprotinin, 5 g/ml leupeptin, and 5 g/ml pepstatin; and 10 mM NaF, 5 mM ␤-glycerophosphate, and 1 mM sodium vanadate, respectively. The HA-tagged Opi1p proteins were immunoprecipitated from cell lysates (0.5 mg of protein) using 4 g of anti-HA antibodies in 0.5 ml of radioimmune immunoprecipitation buffer (42) . The HA-tagged Opi1p proteins were dissociated from enzyme-antibody complexes (42) , subjected to SDS-polyacrylamide gel electrophoresis, and transferred to polyvinylidene difluoride membranes. The Laemmli's sample buffer (39) followed by SDS-polyacrylamide gel electrophoresis, transfer to nitrocellulose paper, and visualized by phosphorimaging. The extent of phosphorylation was analyzed using ImageQuant software. Phosphorylation signals were in the linear range of detectability. Protein kinase C activity was measured using synthetic peptides containing putative phosphorylation sites based on the deduced protein sequence of Opi1p. The indicated concentrations of Opi1p synthetic peptides were phosphorylated with protein kinase C and [␥-32 P]ATP (4 Ci/nmol) for 10 min at 30°C. Loading samples onto phosphocellulose filter paper terminated reactions. The filters were washed with 75 mM phosphoric acid and subjected to scintillation counting. A unit of protein kinase C activity using the Opi1p synthetic peptide GVLKQSCRQK was defined as the amount of enzyme that catalyzed the formation of 1 nmol of product/min. The reactions were performed in triplicate with an average standard deviation of Ϯ3%.
Phosphoamino Acid and Phosphopeptide Map Analyses-MBPOpi1p fusion protein was phosphorylated with protein kinase C and [␥-32 P]ATP for 10 min and then subjected to SDS-polyacrylamide gel electrophoresis. Gel slices containing 32 P-labeled MBP-Opi1p were treated with 50 mM ammonium bicarbonate (pH 8.0) and 0.1% SDS at 37°C for 30 h to elute the enzyme. Bovine serum albumin (50 g) was added to the samples as carrier protein, and trichloroacetic acid was added to a final concentration of 20%. After incubation for 30 min at 4°C, protein precipitates were collected by centrifugation. Proteins were washed three times with cold acetone and dried in vacuo. Samples were then subjected to acid hydrolysis with 6 N HCl at 100°C for 4 h. The hydrolysates were dried in vacuo and applied to 0.1-mm cellulose thin layer chromatography plates with 2.5 g of phosphoserine, 2.5 g of phosphothreonine, and 5 g of phosphotyrosine as carrier phosphoamino acids in water. Phosphoamino acids were separated by twodimensional electrophoresis (43) . Following electrophoresis, the plates were dried, sprayed with 0.25% ninhydrin in acetone to visualize carrier phosphoamino acids, and subjected to phosphorimaging analysis.
Phosphopeptide map analysis was performed on 32 P-labeled MPBOpi1p fusion following CNBr digestion (44) . Phosphorylated proteins were subjected to SDS-polyacrylamide gel electrophoresis, followed by transfer to nitrocellulose membrane. The MBP-Opi1p fusion protein was excised and digested with 0.2 ml of CNBr (100 mg/ml) in 70% formic acid for 1.5 h (44). The mixture was centrifuged, and the supernatant was collected and dried in vacuo. Samples were then suspended in 0.5 ml of deionized water, dried in vacuo, and suspended in 20 l of SDS-polyacrylamide gel electrophoresis buffer. Peptides were separated by SDS-polyacrylamide gel electrophoresis using a 24% slab gel as described previously (44) , and phosphopeptides were identified by phosphorimaging.
RESULTS

Phosphorylation of Opi1p by Protein Kinase C in Vitro-
We examined the hypothesis that Opi1p was a substrate for protein kinase C. To facilitate well defined studies in vitro, Opi1p was expressed in E. coli as an MBP-Opi1p fusion protein and purified to near homogeneity by amylose-agarose affinity chromatography (Fig. 2) . The size of the fusion protein (ϳ95 kDa) was consistent with the combined sizes of MBP and Opi1p. Immunoblot analysis with anti-MBP and anti-Opi1p antibodies confirmed the identity of MBP and Opi1p, respectively, in the fusion protein. When the fusion protein was cleaved with factor Xa, the released Opi1p protein was degraded by the protease. Accordingly, the MBP-Opi1p fusion protein was utilized as a protein kinase C substrate in our studies. Phosphorylation of the MBP-Opi1p fusion was routinely examined with a commercial preparation of purified rat brain protein kinase C. This enzyme preparation contains a mixture of the ␣, ␤, and ␥ isoforms of the enzyme. We used rat brain protein kinase C in our studies because S. cerevisiae protein kinase C (45, 46) has catalytic properties characteristic of the ␣, ␤, and ␥ isoforms of the rat brain enzyme (19, 47) , and phosphorylated the MBPOpi1p fusion protein with the same efficiency as a partially purified preparation of yeast protein kinase C.
To determine if Opi1p was a target for phosphorylation by protein kinase C, we examined whether protein kinase C catalyzed the incorporation of the ␥ phosphate of 32 P-labeled ATP into purified MBP-Opi1p fusion protein. After the phosphorylation reaction, samples were subjected to SDS-polyacrylamide gel electrophoresis and transfer to nitrocellulose paper. Phosphorimaging analysis of the nitrocellulose paper showed that Opi1p was a substrate for protein kinase C (Fig. 3) . The MBP itself was not a substrate for protein kinase C. The position of 32 P-labeled MBP-Opi1p on the nitrocellulose paper was confirmed by immunoblot analysis. The phosphorylation of Opi1p was dependent on the time of the reaction (Fig. 3A) and the concentration of protein kinase C (Fig. 3B) . In addition, protein kinase C activity followed typical saturation kinetics with respect to MBP-Opi1p (Fig. 4A) and with respect to ATP (Fig.  4B ). An analysis of the data according to the Michaelis-Menten equation using the EZ-FIT enzyme kinetic model fitting program (48) yielded K m values for MBP-Opi1p and ATP of 8 g/ml and 18 M, respectively.
Protein kinase C is a serine/threonine-specific protein kinase (19) . To examine which amino acid residue(s) of Opi1p was a target for phosphorylation, MBP-Opi1p was phosphorylated with protein kinase C, and the 32 P-labeled fusion protein was subjected to phosphoamino acid analysis. Protein kinase C primarily phosphorylated Opi1p on a serine residue (Fig. 5) .
Identification of Ser 26 as a Major Protein Kinase C Phosphorylation Site in Opi1p-Examination of the deduced sequence of Opi1p revealed that the protein has four potential serine phosphorylation sites (Ser 26 , Ser 60 , Ser 135 , and Ser 154 ) within a protein kinase C sequence motif. Four peptides, GV-LKQSCRQK, ILDRVSNKII, MSIESKKRLV, and ANKQLSD-KIS containing the potential serine target sites within the protein kinase C sequence motif were synthesized based on the deduced protein sequence of Opi1p. We examined whether these peptides (1 mM) served as substrates for protein kinase C in vitro. Of the four peptides, only the GVLKQSCRQK peptide, which contains the sequence with Ser 26 , was a substrate for protein kinase C. The dependence of protein kinase C activity on the GVLKQSCRQK peptide followed saturation kinetics (Fig. 6 ) with a K m value for the peptide of 0.18 mM. The peptide GVLKQACRQK, which corresponds to a S26A mutation, did not serve as a substrate for protein kinase C (Fig. 6 ).
An OPI1 S26A allele was constructed by site-directed mutagenesis and expressed as an MBP-Opi1p fusion protein in E. coli. The S26A mutant MBP-Opi1p fusion protein was purified to near homogeneity by amylose-agarose affinity chromatography (Fig. 2) and examined for its ability to be phosphorylated by protein kinase C in vitro. The S26A mutant MBP-Opi1p fusion protein was phosphorylated by protein kinase C in a time-dependent (Fig. 7A ) and dose-dependent (Fig. 7B) manner. However, the extent of phosphorylation of the S26A mutant MBP-Opi1p fusion protein was reduced in comparison with the wild-type fusion protein (Fig. 7) . We next examined the effect of the S26A mutation on the phosphopeptide map of the MBP-Opi1p fusion protein. The wild-type and S26A fusion proteins were phosphorylated with protein kinase C and 32 Plabeled ATP. The protein kinase C-phosphorylated wild-type and S26A mutant MBP-Opi1p fusion proteins were then subjected to CNBr cleavage. The resulting peptides were analyzed on a 24% low bis-Tricine SDS gel and visualized by phosphorimaging. The S26A mutation resulted in the loss of the major phosphopeptide present in the wild-type protein (Fig. 8) .
OPI1
S60A , OPI1 S135A , and OPI1 S154A alleles were also constructed, expressed in E. coli as MBP-Opi1p fusion proteins, and purified by amylose-agarose affinity chromatography. The S60A, S135A, and S154A mutations did not affect the ability of protein kinase C to phosphorylate Opi1p, and the phosphopep- tide maps of these mutant proteins did not differ from that of the wild-type protein (data not shown).
Phosphorylation of Opi1p in Vivo-We addressed the question of whether Opi1p was phosphorylated in vivo. For these experiments, we used an epitope-tagged OPI1 allele in the multicopy plasmid pSA1. In this plasmid, the sequence for HA was inserted into the N terminus of the OPI1-coding sequence. Plasmid pSA1 was expressed in an opi1⌬ mutant to avoid interference from Opi1p encoded by the genomic wild-type copy of the OPI1 gene. Immunoblot analysis showed that the epitope-tagged Opi1p protein was specifically recognized in opi1⌬ mutant cells by anti-HA antibodies at the expected molecular mass of about 50 kDa (Fig. 9A) . Moreover, the HA-tagged Opi1p suppressed the inositol excretion phenotype (12) of the opi1⌬ mutant. This indicated that the epitope-tagged protein was functional in vivo. Cells bearing plasmid pSA1 were labeled with 32 P i followed by the immunoprecipitation of the HA-tagged Opi1p from cell extracts with anti-HA antibodies. SDS-polyacrylamide gel electrophoresis of the immunoprecipitate, transfer to nitrocellulose paper, and phosphorimaging analysis revealed that Opi1p was phosphorylated in vivo (Fig. 9B) .
The in vitro experiments indicated that Ser 26 was a phosphorylation site for protein kinase C. We examined the hypothesis that this site was phosphorylated in vivo. A HA-tagged OPI1 S26A allele was constructed in the multicopy plasmid pSA2, and used for the expression of the S26A mutant Opi1p protein in opi1⌬ mutant cells (Fig. 9A) . The effect of the S26A mutation on the phosphorylation of Opi1p was examined by labeling cells with 32 P i . The S26A mutant Opi1p protein was phosphorylated in vivo (Fig. 9B) . However, ImageQuant analysis of the phosphorylated protein revealed that the S26A mutation caused a 50% reduction in phosphorylation for Opi1p when compared with the wild-type control (Fig. 9C) . Immunoblot analysis using anti-HA antibodies showed that the wildtype and S26A mutant Opi1p proteins were present at similar amounts in the immunoprecipitates.
The Effect of the S26A Mutation on Opi1p Function-The Opi1p protein is a transcriptional regulator that represses the expression of several phospholipid synthesis genes that are regulated by inositol supplementation (1, 4 -6 ). An opi1 mutant exhibits elevated expression of phospholipid synthesis enzymes, and the expression of these enzymes does not respond to inositol supplementation (1, 4 -6) . A characteristic property of opi1 mutants is an inositol excretion phenotype (12), which is the result of the derepression of the INO1 gene encoding inositol-1-phosphate synthase (10, 36, 49, 50) . The effect of the S26A mutation in Opi1p on INO1 expression was examined by scoring for the inositol excretion phenotype of opi1⌬ mutant cells using growth of an ino1 mutant on plates lacking inositol. Transformation of the opi1⌬ mutant with a plasmid bearing the OPI1 S26A mutant allele suppressed the inositol excretion phenotype of the opi1⌬ mutant (data not shown). Thus, the S26A mutation did not cause a defect in the negative regulatory function of Opi1p on INO1 expression. Expression of INO1 in opi1⌬ mutant cells was also examined using an INO1-CYC1-lacIЈZ reporter gene, a much more sensitive assay for assessing Opi1p function on INO1 expression than the inositol excretion plate assay (9) . Cells bearing the reporter gene were grown in complete synthetic medium minus inositol, cell extracts were prepared, and ␤-galactosidase activity was measured. Whereas inositol supplementation repressed (4-fold) the ␤-galactosidase activity in wild-type cells, this activity was not affected by inositol in opi1⌬ mutant cells (Fig. 10) as described previously (15) . Under repressing conditions (plus inositol), ␤-galactosidase activity in the opi1⌬ mutant (1.2 units/mg) was 7.5-fold greater than the activity (0.16 unit/mg) in wild-type OPI1 cells (Fig. 10) . The elevated level of ␤-galactosidase activity was consistent with the inositol excretion phenotype of the opi1⌬ mutant. These results are consistent with previous reports of the levels of INO1 mRNA found in wild-type and opi1⌬ mutant cells grown in the absence and presence of inositol (10, 13, 51) .
The effect of the S26A mutation in Opi1p on the expression of INO1 in opi1⌬ mutant cells was examined using the reporter gene. For these experiments, we used HA-tagged OPI1 and OPI1 S26A alleles in the single-copy plasmids pSA3 and pSA4, respectively. Immunoblot analysis using anti-HA antibodies showed that these alleles were expressed at similar levels in opi1⌬ mutant cells. The ␤-galactosidase activity in opi1⌬ mutant cells bearing the wild-type Opi1p protein was 0.2 unit/mg in cells grown under derepressing conditions (minus inositol) (Fig. 10 ). This level of activity was similar to that found in cells with the chromosomal copy of the OPI1 gene except for a somewhat higher background of expression under repressing conditions (plus inositol). This effect has been observed previously in opi1 mutants transformed with an OPI1-bearing plasmid. 2 This has been attributed to a background of elevated INO1 expression coming from opi1⌬ cells that have lost the plasmid. 2 In comparison, ␤-galactosidase activity in opi1⌬ mutant cells bearing the S26A mutant Opi1p protein was nearly 50% lower than that found in opi1⌬ mutant cells bearing the control Opi1p protein under fully derepressing conditions (minus inositol) (Fig. 10) . The addition of inositol to opi1⌬ mutant cells bearing the wild-type or the S26A mutant Opi1p proteins resulted in repression (ϳ2-fold) of ␤-galactosidase activity in both cases (Fig. 10) . As discussed above, in both cases the opi1⌬ cells carrying a complementary wild-type OPI1 or mutant OPI1 S26A allele expressed a higher background level of ␤-galactosidase under repressing conditions.
DISCUSSION
The Opi1p protein, encoded by the OPI1 gene (13), plays a negative regulatory role in the expression of the INO1 gene and other UAS INO -containing genes involved in the synthesis of membrane phospholipids in S. cerevisiae (1, 2, 4 -6) . In this study, we addressed the posttranslational modification of Opi1p by phosphorylation via protein kinase C. Phosphorylation is a major mechanism by which a protein's function may be regulated (52) . Phosphorylation of a regulatory protein can control its ability to bind DNA, its localization, or interaction with other proteins (17, 18, (53) (54) (55) (56) . Our analysis using a MBPOpi1p fusion protein demonstrated that Opi1p was phosphorylated by protein kinase C in vitro. Protein kinase C primarily phosphorylated Opi1p on serine residues, and this reaction was time-and dose-dependent, and dependent on the concentrations of Opi1p and ATP. To our knowledge, this is the first report of the posttranslational modification of a phospholipid synthesis regulatory protein by phosphorylation via protein kinase C.
Computer analysis of the deduced amino acid sequence of the OPI1-encoded Opi1p revealed potential target sites for protein kinase C at Ser 26 , Ser 60 , Ser 135 , and Ser 154 . The peptide GV-LKQSCRQK, which contains the protein kinase C sequence motif at Ser 26 , was shown to be a substrate for protein kinase C in vitro. We also demonstrated that the peptide GV-LKQACRQK, which corresponds to a S26A mutation, failed to 2 J. Anthony Graves, personal communication. FIG. 9 . Effect of the S26A mutation on the phosphorylation of Opi1p in vivo. Cultures (50 ml) of the opi1⌬ mutant bearing the multicopy plasmid pSA1 with the HA-tagged OPI1 gene or the plasmid pSA2 with the HA-tagged OPI1 S26A gene were grown in complete synthetic medium to the exponential phase of growth. Panel A, cells were harvested, cell extracts were prepared, and 25-g samples were subjected to immunoblot analysis using a 1:500 dilution of anti-HA antibodies. WT, wild type. Panel B, cells were harvested, resuspended in 5 ml of fresh medium containing 32 P i (0.25 mCi/ml), and incubated for 3 h. Following the incubation, the HA-tagged Opi1p proteins were immunoprecipitated from 500 g of cell extract with anti-HA antibodies and then subjected to SDS-polyacrylamide gel electrophoresis and transfer to nitrocellulose paper. The S26A gene from the single copy plasmids pSA3 and pSA4, respectively, were transformed with plasmid pJH359, which contains the P INO1 -lacZ reporter gene. Cells were grown in complete synthetic medium in the absence and presence of 75 M inositol. Cells were harvested at the exponential phase of growth; cell extracts were prepared and used for the measurement of ␤-galactosidase activity. The values reported were determined from triplicate determinations from three independent growth studies Ϯ S.D.
serve as a specific substrate for protein kinase C, supporting the conclusion that a protein kinase C target sequence exists within the peptide GVLKQSCRQK. None of the other potential sites proved to be targets by this assay. An MBP-Opi1p fusion protein containing a S26A mutation behaved like the wild-type protein during purification, suggesting that the mutation did not have a significant effect on protein structure. Although protein kinase C phosphorylated the S26A mutant Opi1p protein, the extent of phosphorylation was reduced when compared with the wild-type protein. Moreover, peptide-mapping analysis of protein kinase C-phosphorylated Opi1p proteins showed that a major phosphopeptide present in the wild-type Opi1p protein was absent from the S26A mutant protein, thus confirming that this site is a specific target of protein kinase C. Although Opi1p was phosphorylated by protein kinase C at sites other than Ser 26 , the potential sites at Ser 60 , Ser 135 , and Ser 154 are apparently not the targets since the S60A, S135A, and S154A mutations did not affect the phosphorylation of Opi1p or the phosphopeptide map of the protein.
Opi1p was also phosphorylated in vivo, as demonstrated by immunoprecipitation of labeled HA-tagged Opi1p from labeled cells (Fig. 9) . The degree of phosphorylation was reduced ϳ50% in opi1⌬ cells transformed with the S26A mutant protein tagged with HA as compared with opi1⌬ cells transformed with the wild-type HA-tagged protein. However, the opi1⌬ cells carrying the S26A mutant did not exhibit the inositol excretion phenotype, suggesting that the mutation does not inactivate Opi1p with respect to its function as a transcriptional repressor of INO1 and other UAS INO -containing genes. Indeed, consistent with this result, analysis of INO1 expression monitored using an INO1-CYC1-lacIЈZ reporter gene indicated that INO1 expression does not reach as high a derepressed level in cells carrying the S26A mutation when compared with cells transformed with the wild-type OPI1 control. This result, together with the evidence that phosphorylation of the S26A mutant was reduced compared with the wild-type OPI1 control, indicated that phosphorylation of Ser 26 causes Opi1p to lose a portion of its activity as a negative regulator of INO1. This result implies that Opi1p must be partially inactivated in vivo in order for INO1 to reach maximum derepression. Moreover, the fact that the phosphorylation site in question is a target for protein kinase C suggests that protein kinase C may be involved in the inactivation. If this is the case, the effect of protein kinase C activity on INO1 expression would be positive (i.e. allowing full derepression) via a mechanism involving inactivation of a protein, Opi1p, involved in the mechanism of repression of INO1 and other UAS INO -containing genes. Preliminary data indicate that this is, indeed, the case since pkc1⌬ mutants are inositol auxotrophs. 3 It is not likely that Opi1p functions by binding directly to the UAS INO element in the co-regulated genes or by contacting either of the Ino2p and Ino4p activators (14, 16 ). The precise target of Opi1p is, as yet, unknown. Thus, the precise mechanism of this regulation must await identification of the target of Opi1p activity.
Protein kinase C is a lipid-dependent protein kinase required for S. cerevisiae cell cycle (19 -21, 57, 58) . In mammalian cells, protein kinase C plays a central role in the transduction of lipid second messengers generated by receptor-mediated hydrolysis of membrane phospholipids (59 -61) . The phosphorylation and regulation of Opi1p function by protein kinase C in S. cerevisiae may represent a mechanism by which lipid signal transduction pathways are coordinately regulated to phospholipid synthesis and cell growth.
